Stay updated on PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Sign up to get notified when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.

Latest updates to the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded revision: v3.4.2 to the history and removed revision v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe new screenshot shows a revision label 'Revision: v3.4.1' while the old screenshot shows 'Revision: v3.4.0', reflecting a minor update to the page's version history.SummaryDifference0.1%

- Check27 days agoChange DetectedThe history page introduces a glossary option and adds green and red highlights to show additions and deletions. It also displays a new Revision: v3.4.0 label and updates the No FEAR Act Data capitalization.SummaryDifference1.0%

- Check42 days agoChange DetectedA new 'Study Status' section has been added to the page to display the current status of the study and related updates.SummaryDifference0.5%

- Check63 days agoChange DetectedThe record history now shows a Completed status posted on 2025-12-17 with added sections for Contacts/Locations, Study Design, and Oversight, and updated Study and Recruitment Status. The earlier revision removed the HHS Vulnerability Disclosure link and the Recruiting label.SummaryDifference1%

- Check91 days agoChange DetectedAn additional revision tag v3.3.2 was added and the v3.2.0 revision was removed from the Record History. These are minor metadata updates to the history log that do not affect the page content.SummaryDifference0.1%

Stay in the know with updates to PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.